Tower Research Capital (TRC)’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,898
| Closed | -$2.86K | – | 6373 |
|
|
2023
Q3 | $2.86K | Buy |
32,898
+28,118
| +588% | +$2.45K | ﹤0.01% | 5092 |
|
|
2023
Q2 | $2.68K | Buy |
4,780
+2,135
| +81% | +$1.2K | ﹤0.01% | 5145 |
|
|
2023
Q1 | $3K | Buy |
+2,645
| New | +$3K | ﹤0.01% | 5284 |
|
|
2022
Q4 | – | Sell |
-15,483
| Closed | -$32K | – | 6624 |
|
|
2022
Q3 | $32K | Buy |
+15,483
| New | +$32K | ﹤0.01% | 3568 |
|
|
2022
Q2 | – | Sell |
-3,022
| Closed | -$5K | – | 6762 |
|
|
2022
Q1 | $5K | Buy |
3,022
+1,337
| +79% | +$2.21K | ﹤0.01% | 5142 |
|
|
2021
Q4 | $2K | Sell |
1,685
-6,163
| -79% | -$7.32K | ﹤0.01% | 5714 |
|
|
2021
Q3 | $23K | Buy |
7,848
+1,086
| +16% | +$3.18K | ﹤0.01% | 3613 |
|
|
2021
Q2 | $20K | Sell |
6,762
-9,354
| -58% | -$27.7K | ﹤0.01% | 3907 |
|
|
2021
Q1 | $53K | Buy |
16,116
+12,233
| +315% | +$40.2K | ﹤0.01% | 3079 |
|
|
2020
Q4 | $16K | Sell |
3,883
-2,718
| -41% | -$11.2K | ﹤0.01% | 4023 |
|
|
2020
Q3 | $36K | Buy |
6,601
+1,638
| +33% | +$8.93K | ﹤0.01% | 3670 |
|
|
2020
Q2 | $33K | Buy |
4,963
+4,746
| +2,187% | +$31.6K | ﹤0.01% | 3391 |
|
|
2020
Q1 | $0 | Sell |
217
-11,001
| -98% | – | ﹤0.01% | 4143 |
|
|
2019
Q4 | $79K | Buy |
11,218
+1,764
| +19% | +$12.4K | 0.01% | 1080 |
|
|
2019
Q3 | $36K | Buy |
9,454
+8,829
| +1,413% | +$33.6K | ﹤0.01% | 2033 |
|
|
2019
Q2 | $2K | Sell |
625
-3,392
| -84% | -$10.9K | ﹤0.01% | 3345 |
|
|
2019
Q1 | $14K | Buy |
4,017
+1,890
| +89% | +$6.59K | ﹤0.01% | 2492 |
|
|
2018
Q4 | $16K | Buy |
+2,127
| New | +$16K | ﹤0.01% | 2137 |
|